US Patent 10632191 Synthetic glucopyranosyl lipid adjuvants
Patent 10632191 was granted and assigned to Infectious Disease Research Institute on April, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10632191 Synthetic glucopyranosyl lipid adjuvants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
